NovaGenesis Peptide Research
← Peptide Library
METABOLIC RESEARCHNAD

NAD+

Nicotinamide adenine dinucleotide — a fundamental coenzyme studied for its role in cellular energy production, redox balance, and longevity-related research pathways.

Half-Life
Short
Onset
Moderate
Symbol
NAD
Category
Metabolic

⏱ Half-Life

Short duration profile

NAD+ demonstrates a short half-life characteristic in research literature, shaping how observation windows and study timelines are typically structured.

⚡ Onset Characteristics

Moderate measurable response

Onset is observed as moderate — a property that influences how researchers structure comparative studies versus other compounds in the metabolic research category.

🧠 Key Notes

What makes it distinct

  • 01Central to electron transport and ATP production research
  • 02Frequently studied alongside MOTS-c in metabolic models
  • 03Investigated across cellular ageing and repair pathways

🧬 Mechanism of Action

How it works

NAD+ (nicotinamide adenine dinucleotide) is a fundamental coenzyme present in every living cell. It functions in two major roles: as an electron carrier in the mitochondrial electron transport chain (driving ATP synthesis), and as a substrate for sirtuins (SIRT1–7) and PARP enzymes that govern longevity, DNA repair, and gene silencing. Cellular NAD+ is consumed during these processes and must be continually regenerated. Levels decline measurably with age, contributing to mitochondrial dysfunction, impaired DNA repair, and reduced sirtuin activity. Direct supplementation aims to restore the cofactor pool and reactivate downstream pathways.

✨ Documented Benefits

What the research shows it supports

B01Supports mitochondrial ATP production and cellular energy yield.
B02Activates sirtuin enzymes linked to longevity, metabolic health, and stress resistance.
B03Enhances DNA damage repair via PARP enzyme activity.
B04Improves mental clarity, focus, and energy in research subjects following IV protocols.
B05Supports neuronal health and is studied in neurodegenerative research models.
B06Improves metabolic flexibility and mitochondrial efficiency in age-related research.

🔍 Research Insights

What the literature shows

INSIGHT 01

Required cofactor for sirtuins (SIRT1–7) and PARP enzymes — the central drivers of longevity and DNA-repair pathway research.

INSIGHT 02

Cellular NAD+ levels decline measurably with age in human and animal studies, motivating supplementation models.

INSIGHT 03

Direct IV administration vs precursor pathways (NMN, NR) remains an active comparative research question.

🧪 Typical Research Use Cases

Where it appears in study design

USE CASE 01

Cellular ageing and senescence research.

USE CASE 02

Mitochondrial function and ATP-yield modelling.

USE CASE 03

DNA-repair and sirtuin-pathway studies.

📚 References

Peer-reviewed literature

Primary research sources cited on this profile. All links resolve to PubMed or the publishing journal.

  1. [01]

    Rajman, L., Chwalek, K., & Sinclair, D. A. (2018). Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metabolism, 27(3), 529–547.

    Cell Metabolism ↗
  2. [02]

    Yoshino, J., Baur, J. A., & Imai, S. I. (2018). NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metabolism, 27(3), 513–528.

    Cell Metabolism ↗
  3. [03]

    Imai, S. I., & Guarente, L. (2014). NAD+ and sirtuins in aging and disease. Trends in Cell Biology, 24(8), 464–471.

    Trends in Cell Biology ↗
  4. [04]

    Verdin, E. (2015). NAD+ in aging, metabolism, and neurodegeneration. Science, 350(6265), 1208–1213.

    Science ↗

Continue Exploring

Also explore: MOTS-c, Retatrutide, GHK-Cu

MOTS-c →Retatrutide →GHK-Cu →Half-Life Guide →Metabolic Research →